Hyperfine (HYPR) Current Deferred Revenue (2020 - 2026)

Hyperfine (HYPR) posted Current Deferred Revenue of $1.6 million for Q1 2026, up 2.2% on a QoQ basis from $1.5 million in Q4 2025, and up 12.23% year-over-year from $1.4 million in Q1 2025.

Hyperfine (HYPR) Current Deferred Revenue (2020 - 2026) Analysis & Trends

Hyperfine's Current Deferred Revenue history runs 7 years deep, the most recent figure standing at $1.6 million for Q1 2026.

  • Quarterly Current Deferred Revenue rose 12.23% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 12.23% YoY) and the FY2025 annual result came in at $1.5 million, up 5.75% from the prior year.
  • Current Deferred Revenue was $1.6 million for Q1 2026 at Hyperfine, up from $1.5 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $1.6 million in Q1 2026 and bottomed at $964000.0 in Q2 2022.
  • A 5-year average of $1.4 million and a median of $1.4 million in 2025 frame the typical range for Current Deferred Revenue.
  • Annual changes were most pronounced in 2022 — Current Deferred Revenue jumped 88.77% — and 2025, when it retreated 7.92%.
  • Hyperfine's Current Deferred Revenue stood at $1.4 million in 2022, then climbed by 5.44% to $1.5 million in 2023, then increased by 0.48% to $1.5 million in 2024, then grew by 5.75% to $1.5 million in 2025, then increased by 2.2% to $1.6 million in 2026.
  • Business Quant data shows HYPR's Current Deferred Revenue at $1.6 million in Q1 2026, $1.5 million in Q4 2025, and $1.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Hyperfine 92.81 Mn 51.53 Mn 1.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.58 Mn
Dec 31, 2025 1.54 Mn
Sep 30, 2025 1.44 Mn
Jun 30, 2025 1.37 Mn
Mar 31, 2025 1.41 Mn
Dec 31, 2024 1.46 Mn
Sep 30, 2024 1.41 Mn
Jun 30, 2024 1.43 Mn
Mar 31, 2024 1.53 Mn
Dec 31, 2023 1.45 Mn
Sep 30, 2023 1.45 Mn
Jun 30, 2023 1.49 Mn
Mar 31, 2023 1.42 Mn
Dec 31, 2022 1.38 Mn
Sep 30, 2022 1.45 Mn
Jun 30, 2022 964,000.00
Mar 31, 2022 973,000.00
Dec 31, 2021 730,000.00
Dec 31, 2020 158,000.00